Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
Heart failure drug may treat COVID-19 long-hauler symptom
Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.
Existing drugs could be used to fight COVID-19 in elderly patients
A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.
How will everyone benefit if WTO members sign the TRIPS COVID-19 waiver?
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the TRIPS COVID-19 waiver rejected by the WTO could ramp up global vaccine production.
Covax will protect millions of Pakistanis against COVID-19
The global vaccine facility Covax will help Pakistan’s vaccination programme protect millions of Pakistanis against COVID-19.
Can COVID-19 affect the use of contraception?
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses how the COVID-19 pandemic can affect the use of the pill, the contraceptive patch and the vaginal ring.
Tocilizumab reduces deaths in hospitalised COVID-19 patients
A new trial has found that tocilizumab, an anti-inflammatory treatment, reduces the risk of death in patients hospitalised with COVID-19.
How governments can build on the use of data and tech in fighting COVID-19
George Atalla, EY Global Government & Infrastructure Leader, explores the effect that COVID-19 has had on the use of data and technology in healthcare.
COVID-19 and drugs in the European neighbourhood partnership countries
The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.
HR: Working from home during COVID-19
Helen Watson, Head of Employment Law at Aaron & Partners Solicitors, explores the issues around working from home during COVID-19 in this human resources focus.
COVID-19: The truth about super-spreaders
Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the truth about super-spreaders as part of our focus on COVID-19.
Overcoming the challenges of recruitment in the age of COVID-19
Rachel Robinson, EVP Public Sector Services at Teleperformance, comments on how businesses can successfully recruit, onboard and train new starters all while working remotely.
WHO team in China confirm that COVID-19 came from animals
The WHO team in China have confirmed through their investigation that it is "extremely unlikely" the virus leaked from a lab in Wuhan.
The impact of the COVID-19 pandemic on cancer treatment
Experts from the International Agency for Research on Cancer and the University of Molise chart the impact of the COVID-19 pandemic on cancer treatment.
COVID-19: The challenge of healthcare logistics
Zisis Kozlakidis, International Agency for Research on Cancer, with Erik Steinfelder, Thermo Fisher Scientific, chart the challenges in healthcare logistics in relation to COVID-19.
COVID-19 and coevolving informatics: Defence logic from meiosis to AI
Chris Girard, Associate Professor at Florida International University, explores COVID-19 and coevolving informatics, including comment on defence logic from meiosis to AI.
UK Government and CureVac partnership to tackle COVID-19 virus variants
The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.
UK regulator assures safety of COVID-19 vaccines
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
People with severe mental disorders more likely to die from COVID-19
A new study from Umeå University and Karolinska Institutet has found that people with severe mental disorders have a significantly increased risk of dying from COVID-19.
Over 10 million people receive COVID-19 vaccine
UK reaches significant milestone as more than 10 million people receive the first dose of the COVID-19 vaccine.
Clinical trial looks into mixing different COVID-19 vaccines
A world-first clinical trial looking into mixing different COVID-19 vaccine doses has been backed by £7 million of government funding.